首页> 美国卫生研究院文献>Frontiers in Pharmacology >Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
【2h】

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System

机译:鞘氨醇激酶和鞘氨醇1-磷酸受体:信号和心血管系统中的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The sphingosine kinases 1 and 2 (SphK1 and 2) catalyze the phosphorylation of the lipid, sphingosine, generating the signal transmitter, sphingosine 1-phosphate (S1P). The activation of such kinases and the subsequent S1P generation and secretion in the blood serum of mammals represent a major checkpoint in many cellular signaling cascades. In fact, activating the SphK/S1P system is critical for cell motility and proliferation, cytoskeletal organization, cell growth, survival, and response to stress. In the cardiovascular system, the physiological effects of S1P intervene through the binding and activation of a family of five highly selective G protein-coupled receptors, called S1PR1-5. Importantly, SphK/S1P signal is present on both vascular and myocardial cells. S1P is a well-recognized survival factor in many tissues. Therefore, it is not surprising that the last two decades have seen a flourishing of interest and investigative efforts directed to obtain additional mechanistic insights into the signaling, as well as the biological activity of this phospholipid, and of its receptors, especially in the cardiovascular system. Here, we will provide an up-to-date account on the structure and function of sphingosine kinases, discussing the generation, release, and function of S1P. Keeping the bull’s eye on the cardiovascular system, we will review the structure and signaling cascades and biological actions emanating from the stimulation of different S1P receptors. We will end this article with a summary of the most recent, experimental and clinical observations targeting S1PRs and SphKs as possible new therapeutic avenues for cardiovascular disorders, such as heart failure.
机译:鞘氨醇激酶1和2(SphK1和2)催化脂质鞘氨醇的磷酸化,产生信号传递剂鞘氨醇1-磷酸(S1P)。此类激酶的激活以及随后的S1P产生和在哺乳动物的血清中的分泌是许多细胞信号级联反应中的主要检查点。实际上,激活SphK / S1P系统对于细胞运动和增殖,细胞骨架组织,细胞生长,存活以及对压力的反应至关重要。在心血管系统中,S1P的生理作用通过五个称为S1PR1-5的5个高度选择性G蛋白偶联受体家族的结合和激活进行干预。重要的是,SphK / S1P信号同时存在于血管和心肌细胞上。 S1P是许多组织中公认的生存因子。因此,过去的二十年来,人们对这种磷脂及其受体(尤其是心血管系统)的信号传导以及其生物学活性获得了更多的机械见解,这引起了人们的兴趣和研究工作的兴旺发展,这并不奇怪。 。在这里,我们将提供有关鞘氨醇激酶的结构和功能的最新资料,讨论S1P的产生,释放和功能。密切关注心血管系统,我们将回顾不同S1P受体刺激产生的结构和信号级联以及生物学作用。本文将以针对S1PRs和SphKs的最新,实验和临床观察结果作为总结,作为可能的心血管疾病(例如心力衰竭)新治疗途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号